The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab in patients (pts) with metastatic melanoma.
 
Celine Boutros
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - MSD Oncology
 
Christine Mateus
Honoraria - Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology
 
Emilie Lanoy
No Relationships to Disclose
 
Emilie Routier
No Relationships to Disclose
 
Salem Chouaib
No Relationships to Disclose
 
Dominique Schwob
No Relationships to Disclose
 
Stephan Vagner
No Relationships to Disclose
 
Isabelle Girault
No Relationships to Disclose
 
Caroline Caramella
No Relationships to Disclose
 
Salima Hibat
No Relationships to Disclose
 
yun Gan Tao
No Relationships to Disclose
 
Kim Cao
No Relationships to Disclose
 
Nathalie Chaput
No Relationships to Disclose
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; HalioDx; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Pierre Fabre (Inst); Sanofi (Inst)
 
Jean-Charles Soria
Honoraria - AstraZeneca; Merus; MSD Oncology; Pfizer; Roche; SERVIER; Symphony Evolution
Consulting or Advisory Role - AstraZeneca; Merus; MSD Oncology; Pfizer; Roche; SERVIER; Symphony Evolution
 
Alexander M. Eggermont
Honoraria - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche
 
Eric Deutsch
No Relationships to Disclose
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Novartis; Roche